Logo image of ALMIB.PA

AMOEBA SAS (ALMIB.PA) Stock Fundamental Analysis

EPA:ALMIB - Euronext Paris - Matif - FR0011051598 - Common Stock - Currency: EUR

0.826  +0.02 (+2.48%)

Fundamental Rating

0

ALMIB gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. ALMIB may be in some trouble as it scores bad on both profitability and health. ALMIB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALMIB had negative earnings in the past year.
ALMIB had a negative operating cash flow in the past year.
ALMIB had negative earnings in each of the past 5 years.
ALMIB had a negative operating cash flow in each of the past 5 years.
ALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

ALMIB has a Return On Assets of -116.64%. This is amonst the worse of the industry: ALMIB underperforms 94.12% of its industry peers.
Industry RankSector Rank
ROA -116.64%
ROE N/A
ROIC N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMIB.PA Yearly ROA, ROE, ROICALMIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

1.3 Margins

ALMIB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMIB.PA Yearly Profit, Operating, Gross MarginsALMIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALMIB has more shares outstanding
Compared to 5 years ago, ALMIB has more shares outstanding
Compared to 1 year ago, ALMIB has a worse debt to assets ratio.
ALMIB.PA Yearly Shares OutstandingALMIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALMIB.PA Yearly Total Debt VS Total AssetsALMIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ALMIB has an Altman-Z score of -7.90. This is a bad value and indicates that ALMIB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.90, ALMIB is doing worse than 91.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.9
ROIC/WACCN/A
WACCN/A
ALMIB.PA Yearly LT Debt VS Equity VS FCFALMIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

ALMIB has a Current Ratio of 0.42. This is a bad value and indicates that ALMIB is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMIB has a Current ratio of 0.42. This is amonst the worse of the industry: ALMIB underperforms 92.65% of its industry peers.
A Quick Ratio of 0.37 indicates that ALMIB may have some problems paying its short term obligations.
The Quick ratio of ALMIB (0.37) is worse than 91.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.37
ALMIB.PA Yearly Current Assets VS Current LiabilitesALMIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.20% over the past year.
EPS 1Y (TTM)54.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.72%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ALMIB will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-17.85%
EPS Next 2Y-2.53%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMIB.PA Yearly Revenue VS EstimatesALMIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2025 2026 2027 5M 10M
ALMIB.PA Yearly EPS VS EstimatesALMIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMIB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMIB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMIB.PA Price Earnings VS Forward Price EarningsALMIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMIB.PA Per share dataALMIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15

4.3 Compensation for Growth

ALMIB's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.53%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMIB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMOEBA SAS

EPA:ALMIB (8/5/2025, 7:00:00 PM)

0.826

+0.02 (+2.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-26 2025-03-26
Earnings (Next)10-01 2025-10-01
Inst Owners0.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap56.93M
Analysts89.09
Price Target1.71 (107.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS-0.15
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -116.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 267.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.37
Altman-Z -7.9
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)289.55%
Cap/Depr(5y)177.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.72%
EPS Next Y-17.85%
EPS Next 2Y-2.53%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.03%
EBIT Next 3Y37.15%
EBIT Next 5YN/A
FCF growth 1Y50%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.18%
OCF growth 3YN/A
OCF growth 5YN/A